Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast + Levocetirizine in PAR
NCT01640535Phase 3Completed
- Sponsor
- Hanmi Pharmaceutical
- Start
- Jun 2012
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of montelukast, levocetirizine in perennial allergic rhinitis (PAR), sponsored by Hanmi Pharmaceutical. Started Jun 2012; status: completed.
02
Drugs
montelukastlevocetirizine
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT01640535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01640535.